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Abstract
Background: Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage
of tuberculosis treatment. However, populations living in ‘hard-to-reach’ areas of north-east India have poor access to
health services. Our study aimed to detail treatment outcomes in TB program supported by Me´decins Sans Frontie`res (MSF)
and using an alternative model of TB treatment delivery in Mon district, Nagaland, India.
Methods: This was a retrospective cohort study of TB patients, initiated on self-administered therapy (SAT) through Mon
District Hospital, Nagaland, India between April 2012 and March 2013.
Results: A total of 238 tuberculosis patients had final TB treatment outcomes during the study period, including 82 and 156
from semi-urban and rural areas respectively. The majority of patients (62%, 147/238) were suffering from pulmonary,
smear-positive tuberculosis. Overall, 74% of patients (175/238) had successful outcomes, being cured or having completed
their treatment. Females (81%), pulmonary TB patients (75%) and those on a Category I regimen (79%) had better treatment
success rates than males (67%), extra-pulmonary TB patients (62%) and patients on a Category II regimen (61%). The
univariate and bivariate analyses found age, sex and TB treatment regimen significantly associated with unsuccessful TB
treatment outcomes (defined as death, loss-to-follow-up and failure). However, only older age showed significance in a
multivariate binary logistic regression model.
Conclusion: Our study suggests that self-administered TB treatment is feasible for patients living in areas with limited or no
access to health services. The relatively low number of patients with adverse outcomes suggests that SAT models are safe;
other advantages include the need for fewer resources and less frequent movements by patients. National TB programmes
should consider allowing SAT strategies for delivery of TB treatment to ‘hard-to-reach’ populations, which could in turn help
to achieve universal coverage and contribute to global TB elimination by 2050.
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Introduction
India’s enormous tuberculosis (TB) burden, with an estimated
2.3 million cases annually, contributes more than a quarter of the
global TB burden [1]. Multiple strategies are being adopted by the
Revised National Tuberculosis Control Programme (RNTCP) to
achieve universal coverage of tuberculosis diagnosis and treatment.
However, rural populations such as those living in the hilly terrain
of Nagaland have limited access to health structures due to ‘‘poor
road conditions and lack of basic communication services’’ [2],
which may also hinder completion of TB treatment. The district of
Mon in the state of Nagaland lies in a ‘hard-to-reach’ area near the
Indo-Myanmar border, where several barriers to universal
tuberculosis program coverage exist.
India is working towards the World Health Organization
(WHO) target of an 85% treatment success rate among all
tuberculosis patients [3], including populations in remote and
‘hard-to-reach’ areas. The RNTCP has been present in Nagaland
since 2001 [4]; the entire state is now covered under the
programme, with a total of 3,334 TB patients initiated on
treatment in 2013 [5]. Nagaland and nearby areas in north-
eastern India have a significant proportion of drug users and the
proportion of TB patients co-infected with HIV is 7 percent [5],
which may influence tuberculosis treatment outcomes in such co-
infected patients. Even though, Nagaland state is covered under
the RNTCP, some pockets still need additional support in order to
achieve universal access to TB care and treatment.
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‘‘Directly observed treatment, short course (DOTS)’’ is neces-
sary for the success of a TB control programme, according to the
RNTCP [6]. Direct observation helps to ensure treatment
compliance and limits development of drug resistance [3]. Some
studies have reported on successful treatment outcomes in TB
patients that received their complete treatment under DOTS [7–
9]. However, supervised treatment needs to be adapted to different
settings that are convenient to patients, and there must be
flexibility in how it is applied [10], whether this is in a health
facility, at the workplace, in the community or at home. Human
resource issues may compromise a TB programme that relies
solely on DOT; for example, many regions in the north-east of
India, including Nagaland, do not have enough DOTS providers
to allow supervised treatment of all TB patients. Moreover, a
Cochrane systematic review and meta-analysis detailed no
difference in cure rates between tuberculosis patients taking self-
administered therapy (SAT) or receiving DOTS [11], and
concluded that DOT did not improve outcomes [10]. For these
two reasons, the option of self-administered therapy (SAT) was
offered to TB patients, along with strong adherence support
measures in the TB programme in Mon district, Nagaland.
Since 2010, Me´decins Sans Frontie`res (MSF)/Doctors Without
Borders has been supporting Mon District Hospital, Nagaland,
especially with secondary health services. From 2012, MSF
provided support to the Mon TB programme including supervi-
sion of diagnostic facilities and adherence counseling. Our study
aims to detail treatment outcomes of patients receiving self-
administered treatment for tuberculosis, in this ‘hard-to-reach’
area on the Indo-Myanmar border.
Methods
Ethics
The study satisfied the criteria for reports using routinely
collected programmatic data set by the Me´decins Sans Frontie`res
independent Ethics Review Board in Geneva, Switzerland. As this
was a study of routinely collected monitoring data, informed
consent from the patients was not obtained. The named ethics
committee specifically approved the study and waived the need for
consent.
Study design
This was a retrospective, observational cohort study.
Setting and study population
Nagaland is one of the seven north-eastern states of India
sharing an international border with Myanmar on the east, while
other sides are bounded by Assam, Manipur and Arunachal
Pradesh. Mon is one of 11 districts in Nagaland and the farthest
one from the capital of the state (Kohima). The district is
composed of 14 sub-districts, 2 towns and 131 villages and is
inhabited by the tribal population known as ‘Konyak Nagas’,
which are- one of the major tribes of Nagaland [2]. The
Designated Microscopy Centre (DMC) located in Mon District
Hospital provides TB treatment to the people of Mon district plus
those from Myanmar near the border areas.
The study population consisted of drug-susceptible tuberculosis
patients, initiated on self-administered TB treatment (SAT) in
Mon DMC between April 2012 and March 2013 and for whom
treatment outcomes were available. Patients registered for care
during the study period but who were still on treatment at the end
of October 2013 were excluded.
Tuberculosis treatment delivery
Patients suffering from active tuberculosis in semi-urban Mon
town and nearby villages received treatment under the Mon
DMC. TB patients on both Category I and Category II treatment
regimens were given anti-TB medication three times per week
based on RNTCP guidelines [12]. After diagnosis, patients
received education about TB and its management, plus adherence
counseling by counselors in Mon DMC, with special focus on
alcohol and drug abusers.
For the first two weeks, patients received directly observed
treatment at Mon DMC. Patients from rural areas had to stay in
Mon town with relatives or got admitted in hospital for the two
weeks. After two weeks, trained counselors would determine if
patients were able to initiate self-administered therapy. The hilly
terrain, almost non-existent public transport, poor road connec-
tivity and low number of DOT providers were identified as major
challenges for patients to access DMC for supervised treatment
administration; patients with such challenges were initiated on self-
administered therapy (SAT) for their treatment.
The patients were given medicines for two months (6 weeks
medication and 2 weeks buffer) and advised to return after six
weeks for treatment follow-up. During each follow-up, smear
examinations were carried out for all patients. Other blood
evaluations, including kidney and liver function tests, were carried
out for patients in need. Adherence levels were evaluated by the
empty blister packs and marked calendars brought by patients
during follow-up visits. Patients were reminded about their follow-
up appointments, one week before their appointment, through
mobile phone calls and messages sent to co-villagers.
Data collection and analysis
Demographic and clinical information were systematically
recorded in patient files. The clinical data being routinely collected
for each patient, including treatment and laboratory data, were
entered into an electronic database. A full time data manager
routinely supervised data entry for accuracy and completeness.
Data from all study participants initiated on TB treatment
between April 2012 and March 2013 and having treatment
outcomes were included in the analyses. For the study, patients
receiving tuberculosis treatment were categorized as ‘semi-urban’
(residents of the town where Mon DMC was situated) and ‘rural’
(patients from nearby and distant villages). These rural patients
took 3–4 hours on an average to reach the DMC via foot/private
transport and stayed overnight in Mon town at the home of their
relatives during treatment. Successful outcomes were defined as
bacteriologically confirmed cure or treatment completion, while
adverse outcomes were defined as death, failure or loss to follow
up.
Descriptive statistics were used and comparisons between
subgroups were made by using t-test and/or chi-square test as
appropriate. To explore associations between clinical and demo-
graphic factors and unfavorable TB treatment outcomes, bivariate
and multivariate analyses were performed using binary logistic
regression models. Data analysis was conducted with SPSS
(Release 20, 2011).
Results
Patient characteristics
A total of 238 patients received self-administered TB treatment
(SAT) between April 2012 and March 2013 (Table 1). About half
of the study population belonged to the ‘‘young and productive
age group’’ (aged 16–35 years), while 20% patients were children
aged less than 16 years. The majority (56%) of the patients were
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male. The ratio of pulmonary smear-positive: pulmonary smear-
negative: extra-pulmonary TB was 147:62:29. Among the study
population with recorded HIV status, 0.14% (3/222) TB patients
were co-infected with HIV. The majority (72%) of patients were
receiving Category I treatment [12] for tuberculosis compared to
patients on Category II treatment for tuberculosis (28%).
Among these 238 patients receiving self-administered TB
treatment, 82 patients were from a ‘semi-urban’ area (i.e. Mon
town where the DMC was situated) while the other 156 patients
were from a ‘rural’ area. The demographic and clinical
characteristics of these two groups were compared (Table 2) using
univariate and bivariate analysis. The results of the analysis
showed that age, sex, TB site and treatment regimen was not
statistically different between the groups, thus confirming that the
patients in the ‘semi-urban’ and ‘rural’ groups were similar.
Treatment Outcomes
Overall, 74% (175/238) of the entire study population (i.e.
including patients from semi-urban and rural) were cured or had
completed treatment (Table 3). Females had a higher proportion
(81%) of successful treatment outcomes compared to males (67%).
The pulmonary TB patients had better treatment success rates
(75%) than extra-pulmonary (EPTB) patients (62%). Patients on
category I regimen had more successful treatment outcomes than
patients on category II (79% versus 61%).
To understand the factors associated with unsuccessful TB
treatment outcome in the study population, the demographic and
clinical factors were assessed for association with unsuccessful
outcome. The univariate and bivariate analyses found that age, sex
and TB treatment regimen were significantly related to an
unsuccessful TB treatment outcome. However, none of the factors
other than older age (adjusted Odds Ratio: 1.03, 95% Confidence
Intervals (CI): 1.01–1.05) were associated with unsuccessful TB
treatment outcome in a multivariate binary logistic regression
model.
Discussion
Our study, the first on tuberculosis treatment outcomes from
this district, suggests that self-administered TB treatment (SAT), is
an alternative model for delivery of TB treatment to people living
in areas with limited or no access to health services.
The results demonstrate that successful TB outcomes may be
achieved irrespective of the distance between a person’s home and
the nearest functional TB facility. The majority of study
participants from rural areas, who otherwise would have had to
travel an average of three hours from distant villages to reach Mon
DMC, were instead able to successfully complete their TB
treatment with far less movements. SAT models of care and ‘TB
villages’ have been adopted in various settings for the management
of TB in mobile populations [13,14]. Low numbers of patients
with adverse outcomes in our study and another by Khogali et al
[13] suggest that modified models of treatment delivery can be
considered for ‘hard-to-reach’ populations. Not only do they
require little direct supervision, but such alternative models can
reduce resources required, frequency of movements and stigma felt
by patients from involuntarily disclosure of their TB status, as a
result of multiple visits to a health facility per week to receive
DOT.
The adult (15–49 years) HIV prevalence in state of Nagaland is
0.73 percent [15]. Despite the low prevalence, the areas in the
north-eastern states of India constitute 30% of Injecting drug users
(IDU) of the country [15], which may influence adherence to
tuberculosis treatment [16] and overall treatment outcomes.
Appropriate and effective monitoring systems should be devised
for patients on SAT models, administered by trained counselors
Table 1. Demographic and clinical characteristics of patients receiving self-administered tuberculosis treatment (SAT) in Mon
district, Nagaland, India, 2012–2013.
Characteristics Tuberculosis patients on treatment (N=238)
n (%)
Age (years)
0–15 47 (19.7)
16–25 71 (29.8)
26–35 48 (20.2)
36 and above 72 (30.3)
Sex
Male 132 (55.5)
Female 106 (44.5)
Residence
Rural 156 (65.5)
Semi-urban 82 (34.5)
TB site
Pulmonary, smear-positive 147 (61.8)
Pulmonary, smear-negative 62 (26.1)
Extra-pulmonary 29 (12.2)
TB treatment regimen
Category I 172 (72.3)
Category II 66 (27.7)
doi:10.1371/journal.pone.0108186.t001
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using simple and validated tools [17]. The patients in the study
were reminded about their follow-up appointments through
mobile phone calls and messages sent to co-villagers. Thus, we
must assume that these reminders and other adherence support
measures played a role in the successful TB outcomes seen in this
cohort. National TB programmes should consider use of trained
counselors to improve adherence levels and treatment outcomes of
TB patients in other settings.
Literacy status, distance from health structure [18], quality of
medications administered, daily or intermittent dosages [19], use
of fixed dose combination (FDC) anti-TB therapy versus loose pills
[20] and mode of administration have all been discussed in
previous studies as potential factors associated with TB treatment
outcomes. A study by Nackers et al suggested that self-
administered therapy (SAT) with FDC pills may help in achieving
appropriate adherence to treatment [17]. Although we were not
able to provide FDCs to study population, as these were not
readily available through the national TB programme, we believe
that the use of FDCs would have simplified the TB management,
including counseling sessions for the patients.
The treatment success rate among extra-pulmonary TB (EPTB)
patients in our study are alarmingly lower than the WHO target of
85%, which may indicate late arrival and/or delayed diagnosis
and poor pre-treatment clinical status of such patients. Although
the proportion of study population with HIV/TB co-infection was
small, more than one-third of our cohort was suffering from either
smear-negative TB or EPTB; this finding needs further attention.
Better diagnostic tools are required to allow for prompt diagnosis
and treatment of EPTB cases.
Table 2. Demographic and clinical characteristics of ‘Semi-urban’ and ‘Rural’ patients receiving self-administered tuberculosis
treatment (SAT) in Mon district, Nagaland, India, 2012–2013.
Characteristics ‘Semi-urban’ patients (N=82) n (%) ‘Rural’ patients (N=156) n (%) Chi-square/t-test (p-value)
Age (years, median, IQR) 25.0 (18.0–35.3) 28.0 (17.3–40.0) 0.80 (0.43)
Sex
Male 48 (58.5) 84 (53.8) 0.48 (0.49)
Female 34 (41.5) 72 (46.2)
TB site
Pulmonary, smear-positive 51 (62.2) 96 (61.5) 0.80 (0.67)
Pulmonary, smear-negative 23 (28.0) 39 (25.0)
Extra-pulmonary 8 (9.8) 21 (13.5)
TB treatment regimen
Category I 59 (72.0) 113 (72.4) 0.01 (0.94)
Category II 23 (28.0) 43 (27.6)
IQR: Interquartile range.
doi:10.1371/journal.pone.0108186.t002
Table 3. Demographic and clinical factors associated with unsuccessful treatment outcomes among patients receiving self-
administered TB treatment (SAT) in Mon district, Nagaland, India, 2012–2013.
Explanatory
Variable
Patients with unsuccessful
outcome{ (N=63), n (%)
Patients with successful
outcome{ (N=175), n (%)
Chi-square/t-test
(p-value)
aORa
(95% CI)
Age (years, median, IQR) 36 (22–50) 24 (16–35) 3.81 (,0.01) 1.03 (1.01–1.05)
Sex
Male 43 (32.6) 89 (67.4) 5.68 (0.02) 1.50 (0.78–2.86)
Female 20 (18.9) 86 (81.1)
Residence
Semi-urban 24 (29.3) 58 (70.7) 0.50 (0.48) -
Rural 39 (25.0) 117 (75.0)
TB site
Pulmonary 52 (24.9) 157 (75.1) 2.23 (0.14) -
Extra-pulmonary 11 (37.9) 18 (62.1)
TB treatment regimen
Category I 37 (21.5) 135 (78.5) 7.84 (0.01)
Category II 26 (39.4) 40 (60.6) 1.81 (0.95–3.47)
{Row percentage in parenthesis.
IQR: Inter-quartile range.
aaOR: adjusted Odds Ratios (calculated by binary logistic regression).
doi:10.1371/journal.pone.0108186.t003
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About half of our patients belonged to ‘young and productive’
age group and one-fifth were children suffering from TB. We have
made several efforts to provide tailored adherence counseling
sessions, TB regimens and treatment monitoring tools for these
vulnerable populations. Data from a drug-resistant TB pro-
gramme that cared for a cohort of HIV-infected adolescents in
Mumbai showed extremely poor outcomes [21]. The needs of
adolescents and pediatric patients with all forms of TB are
disturbingly neglected and largely unmet. More patient-centered,
decentralized approaches that include use of patient self-help
groups, family member as DOT provider or community
participation should be considered by TB programmes as opposed
to a ‘‘one-size-fits-all’’ strategy.
The strength of this study was that we were able to examine the
impact of a self-administered therapy model of care in a remote
district with semi-urban and rural areas. This study reflected the
operational reality of piloting an alternative to the DOT model of
TB treatment, in a geographic location under a national
programme that promotes a DOT model but with very limited
resources to support it. We were able to achieve promising results
due to continuous collaboration with the Mon District Hospital
management committee and the national TB program. Our
results were similar for patients in both semi-urban and rural
areas, showing feasibility of the SAT model in developed towns
and remote villages. However, the study findings are limited to
patients registered in one particular setting and may not be
generalizable to other parts of the country. We were not able to
trace the lost-to-follow-up patients who lived far from Mon.
Despite these limitations, we believe that this study documents an
innovative model of care for TB patients living in ‘hard-to-reach’
areas.
Conclusion
In settings where access to TB health services is limited or not
existing, an alternative to the DOTS strategy for TB, such as self-
administered treatment together with adherence support mea-
sures, could allow for successful TB treatment outcomes. National
TB programmes may consider similar innovative models of care
for tuberculosis treatment in order to meet the needs of ‘hard-to-
reach’ populations, as these may help to achieve universal
coverage of TB treatment, and ultimately reduce the burden of
TB in such settings.
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